跳至主要内容
临床试验/NCT03997929
NCT03997929已完成不适用

Prospective Evaluation of 1.3-ß-D-glucan in the Peritoneal Fluid for the Diagnosis of Fungal Peritonitis in Critically Ill Patients

Central Hospital, Nancy, France4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200
试验地点
4
主要终点
Measure of 1.3 BDG in the peritoneal exudate of patient with intra-abdominal candidiasis

研究概览

简要总结

New rapid diagnostic strategies are warranted in intra-abdominal candidiasis (IAC). A previous retrospective study showed that one measure, the day of the surgery, of peritoneal 1.3-Beta-D-Glucan ≤ 310pg/ml could rule out an IAC. This strategy was independent of the patient underlying conditions and Candida risk factors. This study aimed to confirm these results with a multicenter prospective study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • critically ill adult (> 18 yrs old) admitted to ICU for intra-abdominal infection requiring surgery and possible intra abdominal candidiasis

排除标准

  • declinate to participate,
  • expected death within the first 24 hours

结局指标

主要结局

Measure of 1.3 BDG in the peritoneal exudate of patient with intra-abdominal candidiasis

时间窗: 1 DAY

Value of 1.3 BDG in the peritoneal exudate in patient with intra-abdominal candidiasis in comparison with non intra-abdominal candidiasis

次要结局

  • Measure of 1.3 BDG in the serum of patient with intra-abdominal candidiasis(DAY 1 and DAY 3)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验